3-8-dihydroxy-6h-dibenzo(b-d)pyran-6-one and Stroke

3-8-dihydroxy-6h-dibenzo(b-d)pyran-6-one has been researched along with Stroke* in 1 studies

Other Studies

1 other study(ies) available for 3-8-dihydroxy-6h-dibenzo(b-d)pyran-6-one and Stroke

ArticleYear
Urolithin A Prevents Focal Cerebral Ischemic Injury via Attenuating Apoptosis and Neuroinflammation in Mice.
    Neuroscience, 2020, 11-10, Volume: 448

    Neuroinflammation contributes to neuronal death in cerebral ischemia. Urolithin A (UA), a gut microbial metabolite of ellagic acid, has emerged as a potential anti-inflammatory agent. However, its roles and precise mechanisms in stroke remain unknown. Here we found that UA treatment ameliorated infarction, neurological deficit scores, and spatial memory deficits after cerebral ischemia. Furthermore, UA significantly reduced neuron loss and promoted neurogenesis after ischemic stroke. We also found that UA attenuated apoptosis by regulating apoptotic-related proteins. Meanwhile, UA treatment inhibited glial activation via affecting inflammatory signaling pathways, specifically by enhancing cerebral AMPK and IκBa activation while decreasing the activation of Akt, P65NFκB, ERK, JNK, and P38MAPK. Our findings reveal a key role of UA against ischemic stroke through modulating apoptosis and neuroinflammation in mice.

    Topics: Animals; Apoptosis; Brain Ischemia; Coumarins; Mice; Signal Transduction; Stroke

2020